Dechra Pharmaceuticals
$98
48
+$1.9+1.98% Friday 15:28
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Dividends
0%Dividend Yield
Dec 25
$0.78
Apr 25
$0.31
Dec 24
$0.78
Apr 24
$0.31
Apr 23
$0.31
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
26FebExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
8.73%Profit Margin
Profitable874.75MRevenue
76.36MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow DPHAY. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Pharmaceuticals: Other
Health Technology
Manufacturing
Pharmaceutical Preparation Manufacturing
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.
Show more...
CEO
Mr. Ian D. Page
Employees
1998
Country
GB
ISIN
US2434351043
WKN
000A3DRF5
Listings
0 Comments
Share your thoughts
FAQ
What is Dechra Pharmaceuticals stock price today?▼
The current price of DPHAY is $98 USD — it has increased by +1.98% in the past 24 hours. Watch Dechra Pharmaceuticals stock price performance more closely on the chart.
What is Dechra Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dechra Pharmaceuticals stocks are traded under the ticker DPHAY.
What were Dechra Pharmaceuticals earnings last quarter?▼
DPHAY earnings for the last quarter are 0.2 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dechra Pharmaceuticals revenue for the last year?▼
Dechra Pharmaceuticals revenue for the last year amounts to 874.75M USD.
What is Dechra Pharmaceuticals net income for the last year?▼
DPHAY net income for the last year is 76.36M USD.
Does Dechra Pharmaceuticals pay dividends?▼
Yes, DPHAY dividends are paid semi-annual. The last dividend per share was 0.78 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Dechra Pharmaceuticals have?▼
As of April 02, 2026, the company has 1,998 employees.
In which sector is Dechra Pharmaceuticals located?▼
Dechra Pharmaceuticals operates in the Healthcare sector.
When did Dechra Pharmaceuticals complete a stock split?▼
Dechra Pharmaceuticals has not had any recent stock splits.
Where is Dechra Pharmaceuticals headquartered?▼
Dechra Pharmaceuticals is headquartered in Northwich, GB.